Drug Shortage Report for BIAXIN
| Report ID | 255081 |
| Drug Identification Number | 02244641 |
| Brand name | BIAXIN |
| Common or Proper name | CLARITHROMYCIN |
| Company Name | BGP PHARMA ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLARITHROMYCIN |
| Strength(s) | 250MG |
| Dosage form(s) | GRANULES FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | 105ML |
| ATC code | J01FA |
| ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-07-23 |
| Actual start date | |
| Estimated end date | 2025-08-26 |
| Actual end date | |
| Shortage status | Anticipated shortage |
| Updated date | 2025-04-15 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2025-04-15 | French | Compare |
| v1 | 2025-04-15 | English | Compare |
Showing 1 to 2 of 2